Cargando…
Hydroxychloroquine in the prevention of COVID-19 mortality
Autor principal: | Jorge, April |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836264/ https://www.ncbi.nlm.nih.gov/pubmed/33521667 http://dx.doi.org/10.1016/S2665-9913(20)30390-8 |
Ejemplares similares
-
RETRACTED: Chloroquine or hydroxychloroquine for
COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020) -
Hydroxychloroquine for COVID19: The curtains close on a comedy of errors
por: Schwartz, Ilan S, et al.
Publicado: (2022) -
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
por: Funnell, S. G. P., et al.
Publicado: (2020) -
Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
por: Palmeira, Vitória Andrade, et al.
Publicado: (2020) -
Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
por: Biguetti, Claudia, et al.
Publicado: (2020)